Viewing Study NCT00684268


Ignite Creation Date: 2025-12-24 @ 6:25 PM
Ignite Modification Date: 2026-01-06 @ 10:18 AM
Study NCT ID: NCT00684268
Status: COMPLETED
Last Update Posted: 2017-03-27
First Post: 2008-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders
Sponsor: Medical University of Vienna
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module